113 related articles for article (PubMed ID: 2092238)
21. The pill and gynecologic cancer: controversy and mystery prevail.
Sargent MA
J Med Assoc Ga; 1995 Sep; 84(7):320-2. PubMed ID: 7561539
[TBL] [Abstract][Full Text] [Related]
22. Population-based cancer screening.
Champion VL; Rawl SM; Menon U
Oncol Nurs Forum; 2002 Jun; 29(5):853-61. PubMed ID: 12058160
[TBL] [Abstract][Full Text] [Related]
23. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
[TBL] [Abstract][Full Text] [Related]
24. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
Buval'tseva NA; Kvashenko BK
Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
[No Abstract] [Full Text] [Related]
25. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
[TBL] [Abstract][Full Text] [Related]
26. [Cancer-prevention examinations in the woman].
Stoll P
Fortschr Med; 1974 Mar; 92(9):369-72. PubMed ID: 4819505
[No Abstract] [Full Text] [Related]
27. [Our responsibility in the field of gynecologic cancer].
Dolhay B; Jakubecz S; Papp Z; Herpay G; Gardó S
Orv Hetil; 1968 Dec; 109(5):2821-5. PubMed ID: 5717809
[No Abstract] [Full Text] [Related]
28. [Problem of uterine and ovarian cancer mass screening].
Ohmura M; Oda M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
[TBL] [Abstract][Full Text] [Related]
29. Gynecologic cancers: Part. II--risk assessment and screening.
Lee CO
Clin J Oncol Nurs; 2000; 4(2):73-7. PubMed ID: 11107379
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and screening of ovarian cancer.
Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
[TBL] [Abstract][Full Text] [Related]
31. An analysis of the prevalence and incidence of gynecologic cancer cytologically detected in a population of 175,767 women.
Kasper TA; Smith ES; Cooper P; Clayton J; Todd D
Acta Cytol; 1970 May; 14(5):261-9. PubMed ID: 5284264
[No Abstract] [Full Text] [Related]
32. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
[TBL] [Abstract][Full Text] [Related]
33. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
34. [Gynecologic cytological cancer screening over an 11-year period].
Kasabova M; Ganchev I
Akush Ginekol (Sofiia); 1990; 29(3):55-9. PubMed ID: 2252150
[TBL] [Abstract][Full Text] [Related]
35. [Mass screening against endometrial carcinoma].
Salvesen HB
Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1774-6. PubMed ID: 12362687
[TBL] [Abstract][Full Text] [Related]
36. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
37. [A model of the prevention of malignant female genital neoplasms introduced into the gynecological health services in the Bialystok macroregion].
Soszka S; Kazanowska W; Knapp P
Probl Med Wieku Rozwoj; 1983; 12():220-6. PubMed ID: 6674975
[TBL] [Abstract][Full Text] [Related]
38. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
39. [On a mass screening survey for gynecologic carcinomata in a rural community].
Montanari GR; Grismondi GL; Marconato A; Gioia E; Montanari GD
Attual Ostet Ginecol; 1968; 14(5):413-5. PubMed ID: 5737605
[No Abstract] [Full Text] [Related]
40. Colorectal cancer in women: an equal opportunity disease.
Osias GL; Osias KB; Srinivasan R
J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S7-12. PubMed ID: 11794751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
